Table 2 Comparisons between prevalence of the different metabolic abnormalities across the five small countries in Europe

Type 2 diabetes

10.4% (2005)

6.72% (2005–2011)

9.8% (2016–2018)

10.4% (2014–2016)

10.2% (2014)

Obesity (BMI > 30 kg/m²)

25.5% (2008)

26.6% (2017)

19.2% (2016–2018)

34.1% (2014–2016)

25% (2016)

Impaired glucose tolerance

–

–

25.6% (2013–2015)

–

–

Impaired fasting glucose

–

–

–

24.3% (2014–2016)

–

Metabolic syndrome

–

–

28.0% (2008–2009)

26.3% (2014–2016)

–